HGG-16. MOLECULAR PATHOPHYSIOLOGY OF HISTONE 3.3 G34R MUTANT CHILDHOOD BRAIN TUMOURS; TOWARDS THE DEVELOPMENT OF NOVEL TARGETED THERAPIES.

There have been no significant improvements in the treatments for childhood and adolescent High-Grade Glioma (pHGG) and Diffuse Intrinsic Pontine Glioblastoma (DIPG), which have a very poor prognosis. These cancers harbour mutations affecting histone 3 proteins, 80% of DIPGs harbour histone H3.1 and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Haque, Farhana, Foot, Katie, Lordusuamy, Anbarasu, Rahman, Ruman, Layfield, Robert, Grundy, Richard
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
High Grade Glioma
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477229/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars